PSA doubling times in patients with prostate cancer, a potentially useful reflection of tumor doubling time
โ Scribed by Gerald E. Hanks; Barry E. Epstein; Ruth Peter; Timothy E. Schultheiss
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 107 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Numerous racial differences have been reported for carcinoma of the prostate diagnosed in African-American (AA) men when compared to whites. These differences include: (1) a higher incidence in AA compared to whites, (2) a more advanced stage at diagnosis in A4, and (3) higher mortality rates in AA
## BACKGROUND. To understand better the natural history and biology of prostate carcinoma occurring in Japanese patients, the authors attempted to define changes with time in prostate specific antigen (PSA) measurements in 48 men with clinically resectable T1-T3 nonmetastatic disease. ## METHODS.
Background. This study was undertaken to calculate the prostate-specific antigen doubling time (PSA-DT) of prostate cancers recurrent after external beam radiation therapy and to investigate if a correlation exists between the PSA-DT and the clinical behavior of prostate cancer as a possible reflect